These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28961568)

  • 1. MRI in the Assessment of BI-RADS® 4 lesions.
    Leithner D; Wengert G; Helbich T; Morris E; Pinker K
    Top Magn Reson Imaging; 2017 Oct; 26(5):191-199. PubMed ID: 28961568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the applicability of BI-RADS® MRI for the interpretation of contrast-enhanced digital mammography.
    Travieso-Aja MM; Maldonado-Saluzzi D; Naranjo-Santana P; Fernández-Ruiz C; Severino-Rondón W; Rodríguez Rodríguez M; Luzardo OP
    Radiologia (Engl Ed); 2019; 61(6):477-488. PubMed ID: 31262509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neddle-guided biopsy in the diagnosis of non-palpable breast cancer].
    Becerra-Alcántara GI; Círigo-Villagómez LL; Ramos-Medina F; Robledo-Martínez H; Mar-Merinos CG; Panzi-Altamirano RM
    Ginecol Obstet Mex; 2015 Jul; 83(7):400-7. PubMed ID: 26422910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer-Aided Diagnosis in Multiparametric Magnetic Resonance Imaging Screening of Women With Extremely Dense Breasts to Reduce False-Positive Diagnoses.
    Verburg E; van Gils CH; Bakker MF; Viergever MA; Pijnappel RM; Veldhuis WB; Gilhuijs KGA
    Invest Radiol; 2020 Jul; 55(7):438-444. PubMed ID: 32149858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
    Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
    Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI for the assessment of malignancy in BI-RADS 4 mammographic microcalcifications.
    Bennani-Baiti B; Dietzel M; Baltzer PA
    PLoS One; 2017; 12(11):e0188679. PubMed ID: 29190656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Status and Future of BI-RADS in Multimodality Imaging, From the
    Eghtedari M; Chong A; Rakow-Penner R; Ojeda-Fournier H
    AJR Am J Roentgenol; 2021 Apr; 216(4):860-873. PubMed ID: 33295802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging of the breast as a problem-solving method: to be or not to be?
    Oztekin PS; Kosar PN
    Breast J; 2014; 20(6):622-31. PubMed ID: 25200378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concordance of BI-RADS Assessments and Management Recommendations for Breast MRI in Community Practice.
    Lee AY; Ichikawa L; Lee JM; Lee CI; DeMartini WB; Joe BN; Wernli KJ; Sprague BL; Herschorn SD; Lehman CD
    AJR Am J Roentgenol; 2016 Jan; 206(1):211-6. PubMed ID: 26700354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of BI-RADS Assessment Category 4 Subdivisions for Screening Breast MRI.
    Strigel RM; Burnside ES; Elezaby M; Fowler AM; Kelcz F; Salkowski LR; DeMartini WB
    AJR Am J Roentgenol; 2017 Jun; 208(6):1392-1399. PubMed ID: 28792802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Level of suspicion of a mammographic lesion: use of features defined by BI-RADS lexicon and correlation with large-core breast biopsy.
    Bérubé M; Curpen B; Ugolini P; Lalonde L; Ouimet-Oliva D
    Can Assoc Radiol J; 1998 Aug; 49(4):223-8. PubMed ID: 9709675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up results of BI-RADS 3 lesions on magnetic resonance imaging: a retrospective study.
    Aslan Ö; Oktay A; Eroğlu F
    Diagn Interv Radiol; 2024 May; 30(3):175-182. PubMed ID: 38293846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional diagnostic value of MRI in patients with suspicious breast lesions based on ultrasound.
    Sarica O; Uluc F
    Br J Radiol; 2014 Sep; 87(1041):20140009. PubMed ID: 24983629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of breast MRI for BI-RADS category 4B mammographic microcalcification: based on the 5
    Eun NL; Son EJ; Gweon HM; Youk JH; Kim JA
    Clin Radiol; 2018 Aug; 73(8):750-755. PubMed ID: 29853301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multiparametric classification system for lesions detected by breast magnetic resonance imaging.
    Istomin A; Masarwah A; Okuma H; Sutela A; Vanninen R; Sudah M
    Eur J Radiol; 2020 Nov; 132():109322. PubMed ID: 33045483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is a one-year follow-up an efficient method for better management of MRI BI-RADS(®) 3 lesions?
    Boisserie-Lacroix M; Ziadé C; Hurtevent-Labrot G; Ferron S; Brouste V; Lippa N
    Breast; 2016 Jun; 27():1-7. PubMed ID: 27212693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and Outcomes of BI-RADS 3 Lesions on Breast MRI.
    Panigrahi B; Harvey SC; Mullen LA; Falomo E; Di Carlo P; Lee B; Myers KS
    Clin Breast Cancer; 2019 Feb; 19(1):e152-e159. PubMed ID: 30268764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiological features of breast cancer].
    Kettritz U
    Verh Dtsch Ges Pathol; 2005; 89():48-51. PubMed ID: 18035672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of malignancy in palpable solid breast masses considered probably benign or low suspicion: implications for management.
    Giess CS; Smeglin LZ; Meyer JE; Ritner JA; Birdwell RL
    J Ultrasound Med; 2012 Dec; 31(12):1943-9. PubMed ID: 23197547
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.